President to inaugurate indigenous cancer therapy at IIT Bombay

Daily Current Affairs / President to inaugurate indigenous cancer therapy at IIT Bombay

Change Language English Hindi

Category : National Published on: April 05 2024

Share on facebook

This development brings hope to Indian patients, offering the therapy at a significantly reduced cost of ₹40 lakh, in contrast to the exorbitant ₹5 crore expense in the US, rendering it inaccessible to many.
The CAR-T Cell Therapy (used to treat cancer patients) has been developed in India by IIT Bombay-incubated Company Immunoadoptive Cell Therapy (ImmunoACT).
CAR T-Cell therapy, a live drug, is a personalised treatment. Unlike chemotherapy, which must be administered periodically to combat the disease, CAR T-Cell therapy is patient-specific.